Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast

In recent years, the concept of synthetic lethality, describing a cellular state where loss of two genes leads to a non-viable phenotype while loss of one gene can be compensated, has emerged as a novel strategy for cancer therapy. Various compounds targeting synthetic lethal pathways are either und...

Descripción completa

Detalles Bibliográficos
Autores principales: Marhold, Maximilian, Tomasich, Erwin, Schwarz, Michael, Udovica, Simon, Heinzel, Andreas, Mayer, Paul, Horak, Peter, Perco, Paul, Krainer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284748/
https://www.ncbi.nlm.nih.gov/pubmed/30555636
http://dx.doi.org/10.18632/oncotarget.26372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284748/
https://www.ncbi.nlm.nih.gov/pubmed/30555636
http://dx.doi.org/10.18632/oncotarget.26372

Ejemplares similares